Radiation therapy to convert the tumor into an in situ vaccine.
about
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be ExploredUnlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapyTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyNeoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma modelCombinations of immunotherapy and radiation in cancer therapy.Update on treatment of liver metastases: focus on ablation therapies.TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor ImmunityImmunology and Immunotherapy of Head and Neck CancerRadiation as an immunological adjuvant: current evidence on dose and fractionation.Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously.Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanomaOpportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) EraTrial Watch: Immunotherapy plus radiation therapy for oncological indications.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.Immune modulation and stereotactic radiation: improving local and abscopal responses.Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitorsAdvances in local and ablative treatment of oligometastasis in prostate cancer.Combining immunotherapy with radiation for the treatment of glioblastoma.Strategies to relieve immunosuppression in pancreatic cancer.Opportunities and challenges of radiotherapy for treating cancer.Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatmentClinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.Should we be combining local tumor therapies with immunotherapies as standard?Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer.Emerging Opportunities and Challenges in Cancer Immunotherapy.Combinatorial immunotherapy for melanoma.Radiotherapy and immunotherapy: a beneficial liaison?Barriers to Radiation-Induced In Situ Tumor Vaccination.Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma.High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma.Consensus guidelines for the detection of immunogenic cell death.Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev).Radiation and Anti-Cancer Vaccines: A Winning Combination.
P2860
Q26865395-2CCFD163-680F-4939-8BFE-DB6E54997501Q27001216-43B9D0A5-4755-454A-B5FA-DE02A946BF2AQ27004011-6B266356-C0EE-4055-BAD4-F8E7E0070A51Q33859105-0FC42F7A-9F0B-43C8-9EC1-12F4FA98CD41Q33930599-664E9278-E909-40E8-A787-BA2DDE205146Q34582640-32891460-1329-4464-951D-1E61568F17D4Q35443517-2ACBD9FB-5924-4F58-9D76-959CEA805A04Q35908369-F4DB3430-F003-4649-9EE5-904BE4B5F46DQ36100837-370BA34D-D9F0-4FC7-8ACB-7A72D5B02C1BQ36347177-21978F78-3C58-48A7-91FB-266E173C7634Q36356635-9F3DA3AA-715D-444E-B0AF-CA264147E8AAQ36936587-F238F2BE-8A65-4AC7-8962-8AC426B603E8Q37118895-1BE1AE39-699B-4236-9AF3-F35C3DBF82DCQ37308207-51603C38-E1EB-4893-8D84-12740F8E85F9Q37533025-92D46EBB-383F-4FB8-B38B-62B1867029AFQ37567832-998851C7-2E2F-4757-8079-C3E5A94FF096Q37625801-53B72E98-E49B-4015-AD63-82F1899820F4Q38170122-DD082700-3FEB-4B3C-BAAE-5BFB1B555253Q38218134-58F77E46-6397-457B-A6D1-CF03228594EFQ38243113-FC9E3D83-1711-4FE2-8044-1BE2FCF5C34FQ38422623-71F42E7B-D2E4-4A62-AD02-AF226B329D7CQ38445328-63BBDA49-5B4F-4E17-976B-300B19B88EBFQ38539957-C9DE48E5-0A14-4DFE-9D85-6089D5B04750Q38541699-E869A12D-58DD-4744-AD0A-D23CD3B26413Q38543250-84897D7E-DD6A-4AEA-9DC9-3C074512B3D6Q38548397-CB1223E6-9800-4D95-B847-9E084B6A6274Q38638858-0439C7AF-F37B-42DE-95B1-68E5CE61D82FQ38760078-10E7E75B-4FF3-4870-9877-B569433F199AQ38763935-A6B0D9AE-DBE6-41FA-BF9A-216DA87F6567Q38771934-E938EB46-1687-4725-80D3-8A247464877BQ38809772-4D3984B9-5346-479D-B429-43AF984456B6Q39005199-9F484EA4-1480-40C2-9983-E3DD2F539370Q39017268-B62D322B-5A43-4794-9D51-CB818F025E04Q39203685-05183894-3C12-47D0-895D-29F34EA4C9BEQ39208496-63C038D3-7B52-4712-AD16-F7965A9C5B65Q41334725-67F761C5-64C2-4323-85F1-244B95F05742Q41902106-F1E86C7F-F55F-4EAE-9ECA-5F6E86D82132Q42553556-FD18891C-318C-4116-8C8C-27357CB71C41Q43084076-16BF1579-E375-4024-8F1C-A16526196CACQ47547584-2864AE75-7CCC-4AF6-8961-9CCA00BE664F
P2860
Radiation therapy to convert the tumor into an in situ vaccine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Radiation therapy to convert the tumor into an in situ vaccine.
@en
Radiation therapy to convert the tumor into an in situ vaccine.
@nl
type
label
Radiation therapy to convert the tumor into an in situ vaccine.
@en
Radiation therapy to convert the tumor into an in situ vaccine.
@nl
prefLabel
Radiation therapy to convert the tumor into an in situ vaccine.
@en
Radiation therapy to convert the tumor into an in situ vaccine.
@nl
P2860
P1476
Radiation therapy to convert the tumor into an in situ vaccine.
@en
P2093
Silvia C Formenti
P2860
P304
P356
10.1016/J.IJROBP.2012.06.020
P407
P577
2012-11-01T00:00:00Z